Metastatic Cancers Clinical Trials

20 clinical trials for Metastatic Cancers across international registries, including 11 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer — RECRUITING · PHASE1
• Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers — RECRUITING · PHASE2
• e-Motion : Promoting Emotion Regulation in Chronic Cancer — RECRUITING · NA
• A PHASE 1/2, MULTICENTER, OPEN LABEL, DOSE ESCALATION & DOSE EXPANSION STUDY OF JK06, A 5T4 ANTIBODY DRUG CONJUGATE, IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTATIC CANCER — RECRUITING · PHASE1
• Personalized Oncogenomics (POG) Program of British Columbia — RECRUITING · NA
• Assessing Systemic Treatment and ctDNA Monitoring Efficacy in Metastatic Cancer Patients Using K4Care Testing. — RECRUITING
• A RANDOMIZED, OPEN-LABEL, MULTICENTER PHASE 3 TRIAL OF DOMVANALIMAB, ZIMBERELIMAB, AND CHEMOTHERAPY VERSUS NIVOLUMAB AND CHEMOTHERAPY IN PARTICIPANTS WITH PREVIOUSLY UNTREATED LOCALLY ADVANCED UNRESECTABLE OR METASTATIC GASTRIC, GASTROESOPHAGEAL JUNCTION, AND ESOPHAGEAL ADENOCARCINOMA — RECRUITING · PHASE3
• IN VIVO LUNG PERFUSION (IVLP) AS AN ADJUVANT TREATMENT FOR PATIENTS WITH RESECTABLE OR UNRESECTABLE PULMONARY METASTASES OF COLORECTAL CARCINOMAS — RECRUITING
• A PHASE 1/2A TWO-PART, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF OC-001 AS MONOTHERAPY AND IN COMBINATION WITH AN ANTI-PD-L1 ANTIBODY IN PATIENTS WITH SELECTED LOCALLY ADVANCED OR METASTATIC CANCERS — RECRUITING · PHASE1
• PHASE 1 STUDY OF ZW49 IN PATIENTS WITH LOCALLY ADVANCED (UNRESECTABLE) OR METASTATIC HER2-EXPRESSING CANCERS — RECRUITING · PHASE1
• PHASE 1 TRIAL OF ZW25 IN PATIENTS WITH LOCALLY ADVANCED (UNRESECTABLE) AND/OR METASTATIC HER2-EXPRESSING CANCERS — RECRUITING · PHASE1
• Organ-Specific Differences in Immunotherapy Response Among Metastatic Cancer Patients — COMPLETED
• A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies — WITHDRAWN · PHASE2
• Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations — ACTIVE_NOT_RECRUITING · PHASE2
• A PHASE 1/2, FIRST-IN-HUMAN, OPEN-LABEL, DOSE-ESCALATION STUDY OF TAK-280 IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTATIC CANCER — COMPLETED · PHASE1
• Study to Analyze Mutations in V600 BRAF Oncogen in Participants With Metastatic Melanoma — COMPLETED
• EXPRESS: EXcePtional RESponSe - Exceptional and Unexpected Response to Targeted Therapies — COMPLETED · NA
• RADVAX: A Stratified Phase I Trial of Pembrolizumab With Hypofractionated Radiotherapy in Patients With Advanced and Metastatic Cancers — COMPLETED · PHASE1
• Vertebral Augmentation and Radiotherapy of Collapse Spinal Metastatic Cancer — TERMINATED · NA
• Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas — SUSPENDED · PHASE2

Refine this search